宇野司 (Uno Tsukasa) - マイポータル

基本情報

J-GLOBAL ID: 200901072098588808
researchmap会員ID: 5000095526

研究キーワード

研究分野

ライフサイエンス / 医療薬学 /

経歴

MISC

Clinical pharmacokinetics of fexofenadine enantiomers

Masatomo Miura, Tsukasa Uno

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY 6(1) 69-74 2010年1月
Enantioselective disposition of fexofenadine with the P-glycoprotein inhibitor verapamil

Takashi Sakugawa, Masatomo Miura, Nobuo Hokama, Toshio Suzuki, Tomonori Tateishi, Tsukasa Uno

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 67(5) 535-540 2009年5月
Effects of a dopamine receptor agonist and atropine sulfate on absorption of valproic acid in rats

Hiromasa Kameya, Nobuo Hokama, Norio Hobara, Susumu Ohshiro, Tsukasa Uno

BIOMEDICAL RESEARCH-TOKYO 30(2) 101-106 2009年4月
Effects of the P-glycoprotein Inducer Carbamazepine on Fexofenadine Pharmacokinetics

Yamada S, Yasui-Furukori N, Akamine Y, Kaneko S, Uno T

Ther Drug Monit, 2009年
CYP2C19 genotype-based (R)-warfarin disposition assessment: some views on data analysisCYP2C19 genotype-based (R)-warfarin disposition assessment: some views on data analysis

Niioka T, Uno T

J Clin Pharm Ther., 2009年
Effects of the P-glycoprotein Inducer Carbamazepine on Fexofenadine Pharmacokinetics

Yamada S, Yasui-Furukori N, Akamine Y, Kaneko S, Uno T

Ther Drug Monit, 2009年
CYP2C19 genotype-based (R)-warfarin disposition assessment: some views on data analysisCYP2C19 genotype-based (R)-warfarin disposition assessment: some views on data analysis

Niioka T, Uno T

J Clin Pharm Ther., 2009年
The role of cytochrome P2C19 in R-warfarin pharmacokinetics and its interaction with omeprazole

Tsukasa Uno, Katsuyoshi Sugimoto, Kazunobu Sugawara, Tomonori Tateishi

THERAPEUTIC DRUG MONITORING 30(3) 276-281 2008年6月
Effects of the CYP3A5 genotype on omeprazole sulfoxidation in CYP2C19PMs

Katsuyoshi Sugimoto, Tsukasa Uno, Tomonori Tateishi

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 64(6) 583-587 2008年6月
Estimation of the area under the concentration-time curve of racemic lansoprazole by using limited plasma concentration of lansoprazole enantiomers

Takenori Niioka, Masatomo Miura, Tsukasa Uno, Norio Yasui-Furukori, Makoto Hayakari, Tomonori Tateishi, Toshio Suzuki

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 64(5) 503-509 2008年5月
The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers

Tomonori Tateishi, Masatomo Miura, Toshio Suzuki, Tsukasa Uno

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 65(5) 693-700 2008年5月
Limited frequency of the CYP2C19*17 allele and its minor role in a Japanese population

Katsuyoshi Sugimoto, Tsukasa Uno, Hiroshi Yamazaki, Tomonori Tateishi

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY 65(3) 437-439 2008年3月
The effect of CYP2C19 genotypes on the pharmacokinetics of warfarin enantiomers

T. Uno, K. Sugimoto, K. Sugawara, T. Tateishi

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS 33(1) 67-73 2008年2月
Estimation of CYP2C19 activity by the omeprazole hydroxylation index at a single point in time after intravenous and oral administration

Takenori Niioka, Tsukasa Uno, Katsuyoshi Sugimoto, Kazunobu Sugawara, Makoto Hayakari, Tomonori Tateishi

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 63(11) 1031-1038 2007年11月
Simultaneous determination of warfarin enantiomers and its metabolite in human plasma by column-switching high-performance liquid chromatography with chiral separation

Tsukasa Uno, Takenori Niioka, Makoto Hayakari, Kazunobu Sugawara, Tomonori Tateishi

THERAPEUTIC DRUG MONITORING 29(3) 333-339 2007年6月
Pharmacokinetics of low-dose nedaplatin and validation of AUC prediction in patients with non-small-cell lung carcinoma

Takenori Niioka, Tsukasa Uno, Norio Yasui-Furukori, Takenori Takahata, Mikiko Shimizu, Kazunobu Sugawara, Tomonori Tateishi

CANCER CHEMOTHERAPY AND PHARMACOLOGY 59(5) 575-580 2007年4月
A developed determination of midazolam and 1’-hydroxymidazolam in plasma by liquid chromatography-mass spectrometry: Application to human pharmacokinetic study for measurement of CYP3A activity.

Shimizu M, Uno T, Tamura H-I, Kanazawa H, Murakami I, Sugawara K, Tateishi T

J Chromatogr B 847(2) 275-281 2007年3月
Pharmacokinetics of fexofenadine enantiomers in healthy subjects

Masatomo Miura, Tsukasa Uno, Tomonori Tateishi, Toshio Suzuki

CHIRALITY 19(3) 223-227 2007年3月
A developed determination of midazolam and 1'-hydroxymidazolam in plasma by liquid chromatography-mass spectrometry: Application of human pharmacokinetic study for measurement of CYP3A activity

Mikiko Shimizu, Tsukasa Uno, Hiro-omi Tamura, Hideko Kanazawa, Isao Murakami, Kazunobu Sugawara, Tomonori Tateishi

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES 847(2) 275-281 2007年3月
Absolute bioavailability and metabolism of omeprazole in relation to CYP2C19 genotypes following single intravenous and oral administrations

Tsukasa Uno, Takenori Niioka, Makoto Hayakari, Norio Yasui-Furukori, Kazunobu Sugawara, Tomonori Tateishi

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY 63(2) 143-149 2007年2月

もっとみる

宇野司

基本情報

研究キーワード

研究分野

経歴

MISC

共同研究・競争的資金等の研究課題

メニュー